You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (5) |
Back to Search
RATIONAL DESIGN OF LIVER X RECEPTOR (LXR) MODULATORS USING THE AGONIST GW3965 SCAFFOLD AS A LEAD
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Poster
- Poster code: POS-DDD-013
- By: SHOEMAKE, Claire (University of Malta, Pharmacy, Malta)
- Co-author(s): Nicole Bonello: Pharmacy, University of Malta, Msida, Malta
Claire Shoemake: Pharmacy, University of Malta, Msida, Malta - Abstract:
Background
Pancreatic cancer, probably due to characteristic late diagnosis, is associated with high mortality. The Liver-X_Receptor (LXR) is a druggable target for the development of agonists that could mitigate pancreatic cancer development. Literature indicates that experimental molecules GW3965 and 4-(3-Aryloxyaryl) quinoline sulfone have LXR.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026